RUA — Rua Bioscience Share News
0.000.00%
Last trade - 00:00- NZ$11.77m
- NZ$12.99m
- NZ$2.58m
Brief: Rua Bioscience Says First Medicinal Cannabis Dossier For Polish Market Has Now Been Submitted
Brief: Rua Bioscience Says Will Cease Local GMP Manufacturing
Brief: Rua Bioscience Says Anna Stove's Tenure As Managing Director Has Ended
Brief: Rua Bioscience Signs Five-Year Master Supply Agreement With Motagon
Brief: Rua Bioscience Says Rua's R+D Facility At Ruatorea Remains Operational
Brief: Rua Bioscience Says Appointed Paul Naske As Chief Executive Officer
Brief: Rua Bioscience Says It Got First Order Via Nimbus Health
Brief: Rua Bioscience Says Anna Stove Will Lead Business While Board Looks To Appoint New CEO
Brief: Rua Bioscience Signed Agreement With Motagon
Brief: Rua Bioscience CEO Rob Mitchell To Retire
Brief: Rua Bioscience Received Narcotic License For Distribution And Marketing
Brief: Cann Group Says Acquisition Of Zalm Therapeutics By Rua Bioscience Approved By Rua Shareholders
Brief: Rua Bioscience Says Shareholders Approve Zalm Therapeutics Share Issue
NZ's Rua Bioscience acquires rival cannabis co, shares up
Brief: Rua Bioscience Says It Entered Agreement To Acquire Zalm Therapeutics
NZ's Rua Bioscience rises on regulatory nod to produce cannabinoid oil
Brief: Rua Bioscience Posts FY Loss Before Tax Of NZ$6.17 Mln
Brief: Rua Bioscience Says Agreement With Medbloom Ltd Has Been Concluded
Brief: Rua Bioscience Says HY Operating Loss NZ$3.48 Million